O | ||
---|---|---|
OUTLOOK RATING 1..100 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 87 Overvalued | |
PROFIT vs RISK RATING 1..100 | 35 | |
SMR RATING 1..100 | 87 | |
PRICE GROWTH RATING 1..100 | 52 | |
P/E GROWTH RATING 1..100 | 14 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
O | |
---|---|
RSI ODDS (%) | 2 days ago42% |
Stochastic ODDS (%) | 2 days ago64% |
Momentum ODDS (%) | 2 days ago47% |
MACD ODDS (%) | 2 days ago48% |
TrendWeek ODDS (%) | 2 days ago56% |
TrendMonth ODDS (%) | 2 days ago47% |
Advances ODDS (%) | 2 days ago54% |
Declines ODDS (%) | 5 days ago48% |
BollingerBands ODDS (%) | 2 days ago55% |
Aroon ODDS (%) | 2 days ago54% |
A.I.dvisor indicates that over the last year, JRE has been closely correlated with PSA. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if JRE jumps, then PSA could also see price increases.